Related Experiment Video
Updated: Jun 23, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage
Hua Lu1, Ji-Xin Shi, Hui-Lin Chen
1Department of Neurosurgery, Jinling Hospital, Clinical School of Nanjing University, 305 East Zhongshan Road, Nanjing 210002, China.
Abstract:
Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that plays an important role in the recruitment of macrophages. Although previous studies have demonstrated that MCP-1 has been shown to be involved in the damaging inflammatory processes associated with stroke, infection, neoplasia, and others in the central nervous system, the role of MCP-1 in the cerebral artery after experimental subarachnoid hemorrhage (SAH) in rats has been largely unexplored. This study was undertaken to investigate the expression of the MCP-1 in SAH model and to clarify the potential role of MCP-1 in cerebral vasospasm. A total of 80 rats were randomly divided into four groups: control group; day 3, day 5, and day 7 groups. Day 3, day 5, and day 7 groups were all SAH groups. The animals in day 3, day 5 and day 7 groups were subjected to injection of autologous blood into cisterna magna twice on day 0 and day 2 and were killed on days 3, 5, and 7, respectively. Cross-sectional area of basilar artery was measured and the MCP-1 expression was assessed by real-time PCR, Western blot and immunohistochemistry. The cross-sectional area of basilar artery was found to be 85,373+/-8794 mum(2) in control group, 59,210+/-7281 mum(2) in day 3, 50,536+/-6519 mum(2) in day 5, and 66,360+/-7452 mum(2) in day 7, respectively. The basilar arteries exhibited vasospasm after SAH and became more severe on day 5. The elevated mRNA and protein of MCP-1 were detected after SAH and peaked on day 5. MCP-1 is increasingly expressed in a parallel time course to the development of cerebral vasospasm in a rat experimental model of SAH and these findings might have important implications during the administration of specific MCP-1 antagonists in order to prevent or reduce cerebral vasospasm caused by SAH.
Insights
Monocyte chemoattractant protein-1 (MCP-1) levels increase with cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats. Targeting MCP-1 may help prevent or reduce vasospasm following SAH.
Area of Science:
- Neuroscience
- Immunology
- Vascular Biology
Background:
- Monocyte chemoattractant protein-1 (MCP-1) is a key chemokine in macrophage recruitment.
- MCP-1 is implicated in central nervous system inflammation but its role in cerebral vasospasm post-subarachnoid hemorrhage (SAH) is understudied.
Purpose of the Study:
- To investigate MCP-1 expression in a rat model of SAH.
- To clarify the potential role of MCP-1 in the development of cerebral vasospasm.
Main Methods:
- An experimental SAH model was created in 80 rats, divided into control and SAH groups (days 3, 5, 7).
- Basilar artery cross-sectional area was measured.
- MCP-1 expression was assessed using real-time PCR, Western blot, and immunohistochemistry.
Main Results:
- Subarachnoid hemorrhage induced significant basilar artery vasospasm, peaking on day 5.
- Elevated MCP-1 mRNA and protein levels were detected post-SAH, mirroring the vasospasm timeline.
- MCP-1 expression correlated with the severity of cerebral vasospasm.
Conclusions:
- MCP-1 expression parallels the development of cerebral vasospasm after experimental SAH in rats.
- These findings suggest MCP-1 antagonists could be a therapeutic strategy for mitigating SAH-induced vasospasm.